advertisement
Abstract #8027 Published in IGR 4-3
Results of transscleral diode laser cyclophotocoagulation for refractory glaucoma after penetrating keratoplasty
Shimomura N; Amano S; Oshika T; Kasuya T; Hara TJapanese Journal of Clinical Ophthalmology 2002; 56: 1267-1270
The authors treated 20 eyes of glaucoma after penetrating keratoplasty by transscleral diode laser cyclophotocoagulation. All the eyes had failed to achieve control of intraocular pressure (IOP) by medication. They used a diode laser with 800 nm in wavelength, two seconds each for exposure, power output from 500-2000 mW, and 10-40 exposures per session. After follow-up of 15-265 weeks, average 103 weeks, the average IOP decreased to 23 mmHg from the pretreatment level of 39 mmHg. IOP decreased in 19 eyes with medication. IOP decreased below 21 mmHg in 13 eyes (65%) without medication, including seven eyes which attained IOP control after a single session. Loss of light perception occurred in two eyes and vitreous hemorrhage in one eye. The donor cornea was initially transparent in 14 eyes. It became opaque in six eyes after treatment. The findings show that transscleral diode laser cyclophotocoagulation is relatively safe and effective for refractory glaucoma after penetrating keratoplasty. LA: Japanese
N. Shimomura, MD, Department of Ophthalmology, Doaikinen Hospital, 2-1-11 Yokoami Sumida-ku, Tokyo 130-8587, Japan
Classification:
12.10 Cyclodestruction (Part of: 12 Surgical treatment)